Although you were being sarcastic, today’s SA article is in fact a pretty good summary of the recent price action. The article has a few minor misstatements, but it gets the main point right: Bavituximab is almost certainly not the miraculously late-blooming miracle drug that PPHM longs claim it to be.
Market Data 
Markets 
AI
